H U Group Holdings's Total Assets for the quarter that ended in Mar. 2026 was $1,686 Mil.
During the past 12 months, H U Group Holdings's average Total Assets Growth Rate was -8.10% per year.
During the past 3 years, the average Total Assets Growth Rate was -4.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 0.60% per year.
During the past 10 years, the average Total Assets Growth Rate was 3.80% per year.
During the past 13 years, H U Group Holdings's highest 3-Year average Total Assets Growth Rate was 24.50%. The lowest was -12.90%. And the median was 3.10%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
H U Group Holdings's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
H U Group Holdings Total Assets Related Terms
H U Group Holdings Total Assets Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
H U Group Holdings's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (MRCHF) has a Total Assets of $1,686 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on H U Group Holdings and its competitors.
Is H U Group Holdings' Total Assets too high?
H U Group Holdings' current Total Assets is $1,686 Mil. Overall, H U Group Holdings has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Total Assets compare to TMO and DHR?
H U Group Holdings' Total Assets of $1,686 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Total Assets is $1,686 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (MRCHF) is currently considered Fairly Valued. The stock's GF Value™ is $19.06, compared to a current price of $20.94 — trading 9.9% above its estimated fair value. The current Total Assets is $1,686 Mil. H U Group Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For H U Group Holdings (MRCHF), the current Total Assets is $1,686 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (MRCHF) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of $20.94 is trading 9.9% above its estimated GF Value™ of $19.06.
GuruFocus considers H U Group Holdings to be Fairly Valued.
Key valuation signals for MRCHF:
Total Assets: $1,686 Mil
GF Value™: $19.06 vs. price of $20.94 (9.9% above fair value)
No single metric tells the full story. See the MRCHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
67GF Score
Get the complete analysis for MRCHF
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRCHF has been successfully added to your 
